Experience
Pfenex Inc.
GlaxoSmithKline Biologicals SA
Representing patent owner GlaxoSmithKline Biologicals SA in multiple inter partes review (IPR) proceedings involving vaccine production patents.
Pfenex Inc. v. GlaxoSmithKline Biologicals SA, IPR2019-01027, -01028, PTAB
Merck Sharp & Dohme Corp. v. GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA
Danisco US Inc. v. Novozymes A/S
Danisco US Inc.
Unified Patents Inc. v. Velos Media, LLC
Unified Patents Inc.
Sandoz, Inc. et al v. Pharmacyclics LLC
Pharmacyclics LLC; Janssen Biotech, Inc.
ClearOne, Inc. v. Shure Acquisition Holdings, Inc.
Shure Acquisition Holdings, Inc.
Auris Health, Inc. v. Intuitive Surgical Operations
Intuitive Surgical Operations
William Hill U.S. Holdco, Inc. v. CG Technology Development, LLC
CG Technology Development, LLC
Google LLC
NetApp, Inc./HPE et al. v. KOM Software Inc.
NetApp, Inc/HPE et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.